MBX Biosciences (MBX) Liabilities and Shareholders Equity (2023 - 2026)
MBX Biosciences' Liabilities and Shareholders Equity came in at $435.91 million for Q2 2026, up 88.3% from $231.52 million a year earlier but down 3.7% from the prior quarter.
Powered by 
Analysis
MBX Biosciences (MBX) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, MBX Biosciences' Liabilities and Shareholders Equity was $385.14 million, up 43.4% from FY2024.
- Going back by year, Liabilities and Shareholders Equity was $268.54 million in FY2024 (+219.0%) and $84.18 million in FY2023.
- The five-year range for quarterly Liabilities and Shareholders Equity is $84.18 million (Q4 2023) to $452.7 million (Q1 2026).
- Year-over-year, Liabilities and Shareholders Equity has increased for four consecutive quarters, with growth averaging 95.3% over the last five quarters.
- Business Quant data shows MBX's Liabilities and Shareholders Equity at $452.7 million (Q1 2026), $385.14 million (Q4 2025) and $400.08 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 201.13 Bn |
| 10 | MBX Biosciences | 2.31 Bn | 689.81 Mn | - | 435.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 435.91 Mn |
| Mar 31, 2026 | 452.70 Mn |
| Dec 31, 2025 | 385.14 Mn |
| Sep 30, 2025 | 400.08 Mn |
| Jun 30, 2025 | 231.52 Mn |
| Mar 31, 2025 | 245.93 Mn |
| Dec 31, 2024 | 268.54 Mn |
| Sep 30, 2024 | 282.40 Mn |
| Dec 31, 2023 | 84.18 Mn |
API Access
MBX Biosciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "MBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();